June 29, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Marketing and Manufacturing Approval Received for TENELIA® 20mg Tablets

First Page		Document Content
Date: 2012-09-04 21:13:37 Mitsubishi Glucagon-like peptide-1 Economy of Asia Mitsubishi companies Mitsubishi Pharma Dipeptidyl peptidase-4 inhibitors Economy of Japan Daiichi Sankyo Chūō-ku Osaka		June 29, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Marketing and Manufacturing Approval Received for TENELIA® 20mg Tablets Add to Reading List Source URL: www.mt-pharma.co.jp Download Document from Source Website File Size: 34,92 KB Share Document on Facebook

	Etizolam (Depas, Etilaam, Etizest) Stephanie Hopkins, California Department of Justice, 4949 Broadway, Room F-249, Sacramento CA, Manufacturer: Mitsubishi Pharma Corporation Chemical N DocID: 1uYvB - View Document
	A Novel Descriptor Based on Atom-Pair Properties Masataka Kuroda Mitsubishi Tanabe Pharma Corporation Descriptors can be classified into several groups. Property and fingerprint belong to zero and one dimensional descri DocID: 1sCFD - View Document
	Contribution to Academic Study and Research for the Future 　　 Index DocID: 1qT3z - View Document
	EXHIBITION FREE OF CHARGE: 1. Enjoy our free voice guide machine! (English, Chinese, Korean and Japanese) DocID: 1owUL - View Document
	April 4, 2016 Press Release Mitsubishi Tanabe Pharma Corporation MT Pharma Singapore Pte. Ltd. Starts Business Operations Mitsubishi Tanabe Pharma’s Subsidiary in Singapore DocID: 1mvDN - View Document